Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
Open accessThe DOI matches its Crossref record; 273 of the 274 references it cites were found in a registry or an index.
Abstract
Studies of psychiatric disorders have traditionally focused on emotional symptoms such as depression, anxiety and hallucinations. However, poorly controlled cognitive deficits are equally prominent and severely compromise quality of life, including social and professional integration. Consequently, intensive efforts are being made to characterize the cellular and cerebral circuits underpinning cognitive function, define the nature and causes of cognitive impairment in psychiatric disorders and identify more effective treatments. Successful development will depend on rigorous validation in animal models as well as in patients, including measures of real-world cognitive functioning. This article critically discusses these issues, highlighting the challenges and opportunities for improving cognition in individuals suffering from psychiatric disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because memory impairments were observed in MDD patients (Dere et al. 2010; Millan et al. 2012), the recovery of memory deficits in animal models of AD after administration of DHF could be expected.”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Millan et al. 2012
In the citing paper
“Executive dysfunction (ED) is a transdiagnostic factor in various psychopathologies (13,14)”
From Impact of Childhood Trauma on Executive Function in Adolescence—Mediating Functional Brain Networks and Prediction of High-Risk Drinking (2020) · cites this paper as [13]
In the citing paper
“Pair-bond formation is a social cognitive process that involves both social recognition and social reward (27–29) and models a human attachment relationship far more closely than do the social interactions of adult mice or rats.”
From Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles (2013) · cites this paper as [27]
In the citing paper
“The prairie vole (Microtus ochrogaster), a socially monogamous rodent native to the American Midwest (24), is the premier animal model for the neurobiology of social bonding (25) and increasingly used to screen drugs that have therapeutic potential for social disorders such as autism (26,27).”
From Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles (2013) · cites this paper as [27]
In the citing paper
“The pathways whereby this effect occurs are opaque; changes in appetite and energy balance may have negative effects on cognition because interference in the metabolism of glucose may lead to insulin resistance [84], abnormal neurotransmitter turnover, mitochondrial dysfunction, and energy deficits, as well as changes in neural plasticity [85].”
From Cognitive remission: a novel objective for the treatment of major depression? (2016) · cites this paper as [85]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Complex brain networks: graph theoretical analysis of structural and functional systems
Bullmore, E., & Sporns, O. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2575 · Cited by 11,820 · cited 1×
“Networks that modulate cognition display considerable redundancy and pleiotropy at all levels of integration: from intracellular signals, to neurons, to cerebral nucle”
BackgroundSelf-citationParallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
Effects of stress throughout the lifespan on the brain, behaviour and cognition
Lupien, S. J., McEwen, B. S., Gunnar, M. R., & Heim, C. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2639 · Cited by 6,256
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Yatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
Cattaneo, L., & Rizzolatti, G. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.41 · Cited by 3,137
On the relationship between emotion and cognition
Pessoa, L. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2317 · Cited by 2,350 · cited 16×
“Specificity relative to generalized changes in overall intelligence remains under discussion, in 1Institut de Recherche Servier, 78290 Croissy/Seine, France.”
InfluentialNew neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?
Deng, W., Aimone, J. B., & Gage, F. H. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2822 · Cited by 2,120 · cited 1×
“This is perhaps not surprising, as both deficient and excessive LTP, LTD, 'plasticity gene' activity, neurogenesis and dendritic spine generation have a deleterious effect on cognitive processin”
BackgroundNeurophysiological and Computational Principles of Cortical Rhythms in Cognition
Wang, X.-J. (2010) · Physiological Reviews · doi:10.1152/physrev.00035.2008 · Cited by 1,939 · cited 1×
“Finally, representing a level of integration that is intermediate between cells and cerebral circuits, neurons do not generally act in isolation; rather, they operate as synchronized and rhythmically active assemblies to encode, transmit and modulate information underpinning cognitive functio”
BackgroundThe Social Brain: Neural Basis of Social Knowledge
Adolphs, R. (2009) · Annual Review of Psychology · doi:10.1146/annurev.psych.60.110707.163514 · Cited by 1,827
Cited by
Kahn, R. S., Sommer, I. E., Murray, R. M., Meyer-Lindenberg, A., Weinberger, D. R., Cannon, T. D., O'Donovan, M., Correll, C. U., Kane, J. M., van Os, J., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.67 · Cited by 1,124
Self-citationMcIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836
Self-citationFox, K. C. R., Nijeboer, S., Dixon, M. L., Floman, J. L., Ellamil, M., Rumak, S. P., Sedlmeier, P., & Christoff, K. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.016 · Cited by 804
Brunoni, A. R., & Vanderhasselt, M.-A. (2014) · Brain and Cognition · doi:10.1016/j.bandc.2014.01.008 · Cited by 669
Phillips, K. A., Bales, K. L., Capitanio, J. P., Conley, A., Czoty, P. W., ‘t Hart, B. A., Hopkins, W. D., Hu, S., Miller, L. A., Nader, M. A., et al. (2014) · American Journal of Primatology · doi:10.1002/ajp.22281 · Cited by 612
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Vollenweider, F. X., & Preller, K. H. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0367-2 · Cited by 570
Sanchez, C., Asin, K. E., & Artigas, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.07.001 · Cited by 547
Psychosis as a transdiagnostic and extended phenotype in the general population
van Os, J., & Reininghaus, U. (2016) · World Psychiatry · doi:10.1002/wps.20310 · Cited by 531
Altering the course of schizophrenia: progress and perspectives
Millan, M. J., Andrieux, A., Bartzokis, G., Cadenhead, K., Dazzan, P., Fusar-Poli, P., Gallinat, J., Giedd, J., Grayson, D. R., Heinrichs, M., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.28 · Cited by 516
Self-citationFineberg, N. A., Chamberlain, S. R., Goudriaan, A. E., Stein, D. J., Vanderschuren, L. J. M. J., Gillan, C. M., Shekar, S., Gorwood, P. A. P. M., Voon, V., Morein-Zamir, S., et al. (2014) · CNS Spectrums · doi:10.1017/s1092852913000801 · Cited by 488
“Intensive efforts have been made to characterize the cerebral circuits that underpin cognitive traits and to define their genetic vulnerability, which would potentially lead to new effective treatments in psychiatry.(212) The impulsivity trait is one of the most frequently studied traits in this regard.”
BackgroundResultSelf-citationMaj, M., Stein, D. J., Parker, G., Zimmerman, M., Fava, G. A., De Hert, M., Demyttenaere, K., McIntyre, R. S., Widiger, T., & Wittchen, H. (2020) · World Psychiatry · doi:10.1002/wps.20771 · Cited by 435
Cognitive impairment in depression: recent advances and novel treatments
Perini, G., Cotta Ramusino, M., Sinforiani, E., Bernini, S., Petrachi, R., & Costa, A. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s199746 · Cited by 384
Patki, G., Solanki, N., Atrooz, F., Allam, F., & Salim, S. (2013) · Brain Research · doi:10.1016/j.brainres.2013.09.033 · Cited by 380
Common Dysfunction of Large-Scale Neurocognitive Networks Across Psychiatric Disorders
Sha, Z., Wager, T. D., Mechelli, A., & He, Y. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.11.011 · Cited by 367
Hassani, S. A., Oemisch, M., Balcarras, M., Westendorff, S., Ardid, S., van der Meer, M. A., Tiesinga, P., & Womelsdorf, T. (2017) · Scientific Reports · doi:10.1038/srep40606 · Cited by 360
Hill, S. K., Reilly, J. L., Keefe, R. S. E., Gold, J. M., Bishop, J. R., Gershon, E. S., Tamminga, C. A., Pearlson, G. D., Keshavan, M. S., & Sweeney, J. A. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12101298 · Cited by 354
Self-citationMotivation and cognitive control in depression
Grahek, I., Shenhav, A., Musslick, S., Krebs, R. M., & Koster, E. H. W. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.011 · Cited by 348
Millan, M. J., Fone, K., Steckler, T., & Horan, W. P. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.008 · Cited by 347
Self-citationRudolph, U., & Möhler, H. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135947 · Cited by 319
Wang, X.-J., & Krystal, J. H. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.018 · Cited by 312
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4950-4 · Cited by 308
The Potential of HDAC Inhibitors as Cognitive Enhancers
Gräff, J., & Tsai, L.-H. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140216 · Cited by 298
Cognitive dysfunction in unipolar depression: Implications for treatment
Trivedi, M. H., & Greer, T. L. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.09.012 · Cited by 294
The Mediodorsal Thalamus: An Essential Partner of the Prefrontal Cortex for Cognition
Parnaudeau, S., Bolkan, S. S., & Kellendonk, C. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.11.008 · Cited by 289
Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model
Mathew, A. R., Hogarth, L., Leventhal, A. M., Cook, J. W., & Hitsman, B. (2017) · Addiction · doi:10.1111/add.13604 · Cited by 276
Koster, E. H. W., Hoorelbeke, K., Onraedt, T., Owens, M., & Derakshan, N. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.02.002 · Cited by 273
PTSD symptoms among health workers and public service providers during the COVID-19 outbreak
Johnson, S. U., Ebrahimi, O. V., & Hoffart, A. (2020) · PLOS ONE · doi:10.1371/journal.pone.0241032 · Cited by 272
The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders
Stone, T. W., & Darlington, L. G. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12230 · Cited by 271
Cognitive Effects of Nicotine: Recent Progress
Valentine, G., & Sofuoglu, M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171103152136 · Cited by 271
The C factor: cognitive dysfunction as a transdiagnostic dimension in psychopathology
Abramovitch, A., Short, T., & Schweiger, A. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.102007 · Cited by 269
“…cognitive deficiencies across domains may be the rule rather than the exception (Bloemen et al., 2018; Castaneda, Tuulio-Henriksson, Marttunen, Suvisaari, & Lonnqvist, 2008; Doyle et al., 2018; East-Richard, Alexandra, Nadeau, & Cellard, 2019; Millan et al., 2012; Snyder, Miyake, & Hankin, 2015).”
Bales, K. L., Perkeybile, A. M., Conley, O. G., Lee, M. H., Guoynes, C. D., Downing, G. M., Yun, C. R., Solomon, M., Jacob, S., & Mendoza, S. P. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.08.025 · Cited by 265
“The prairie vole (Microtus ochrogaster), a socially monogamous rodent native to the American Midwest (24), is the premier animal model for the neurobiology of social bonding (25) and increasingly used to screen drugs that have therapeutic potential for social disorders such as autism (26,27).”
Cognitive remission: a novel objective for the treatment of major depression?
Bortolato, B., Miskowiak, K. W., Köhler, C. A., Maes, M., Fernandes, B. S., Berk, M., & Carvalho, A. F. (2016) · BMC Medicine · doi:10.1186/s12916-016-0560-3 · Cited by 252
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
Wei, Y., Chang, L., & Hashimoto, K. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01121-1 · Cited by 248
“autism spectrum disorder, attention-deficit hyperactivity disorder, and panic disorder [165].”
BackgroundComorbidity in multiple sclerosis: implications for patient care
Marrie, R. A. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.33 · Cited by 248
Meier, M. H., Caspi, A., Reichenberg, A., Keefe, R. S. E., Fisher, H. L., Harrington, H., Houts, R., Poulton, R., & Moffitt, T. E. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12111438 · Cited by 244
Short‐term neuropsychiatric outcomes and quality of life in COVID‐19 survivors
Méndez, R., Balanzá‐Martínez, V., Luperdi, S. C., Estrada, I., Latorre, A., González‐Jiménez, P., Feced, L., Bouzas, L., Yépez, K., Ferrando, A., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13262 · Cited by 241
Moffitt, T. E., & Tank, T. K.-G. 2. T. (2013) · Development and Psychopathology · doi:10.1017/s0954579413000801 · Cited by 236
NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
Snyder, M. A., & Gao, W.-J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00031 · Cited by 236
An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy
Millan, M. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.015 · Cited by 229
Self-citationDolcos, F., Katsumi, Y., Moore, M., Berggren, N., de Gelder, B., Derakshan, N., Hamm, A. O., Koster, E. H. W., Ladouceur, C. D., Okon-Singer, H., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.08.017 · Cited by 221
Xia, M., Liu, J., Mechelli, A., Sun, X., Ma, Q., Wang, X., Wei, D., Chen, Y., Liu, B., Huang, C.-C., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01519-5 · Cited by 221
Effects of chronic stress on cognitive function – From neurobiology to intervention
Girotti, M., Bulin, S. E., & Carreno, F. R. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100670 · Cited by 209
Danese, A., Moffitt, T. E., Arseneault, L., Bleiberg, B. A., Dinardo, P. B., Gandelman, S. B., Houts, R., Ambler, A., Fisher, H. L., Poulton, R., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16030333 · Cited by 195
Novel therapeutic targets in depression: Minocycline as a candidate treatment
Soczynska, J. K., Mansur, R. B., Brietzke, E., Swardfager, W., Kennedy, S. H., Woldeyohannes, H. O., Powell, A. M., Manierka, M. S., & McIntyre, R. S. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.026 · Cited by 189
Stratified medicine for mental disorders
Schumann, G., Binder, E. B., Holte, A., de Kloet, E. R., Oedegaard, K. J., Robbins, T. W., Walker-Tilley, T. R., Bitter, I., Brown, V. J., Buitelaar, J., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.09.010 · Cited by 186
Self-citationCognition, The Menstrual Cycle, and Premenstrual Disorders: A Review
Le, J., Thomas, N., & Gurvich, C. (2020) · Brain Sciences · doi:10.3390/brainsci10040198 · Cited by 184
Serotonin and emotion, learning and memory
Meneses, A., & Liy-Salmeron, G. (2012) · Reviews in the Neurosciences · doi:10.1515/revneuro-2012-0060 · Cited by 183
Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap
Pratt, J., Winchester, C., Dawson, N., & Morris, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3649 · Cited by 183
Early-life adversity and neurological disease: age-old questions and novel answers
Short, A. K., & Baram, T. Z. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0246-5 · Cited by 183
The potential role of dopamine D3 receptor neurotransmission in cognition
Nakajima, S., Gerretsen, P., Takeuchi, H., Caravaggio, F., Chow, T., Le Foll, B., Mulsant, B., Pollock, B., & Graff-Guerrero, A. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.05.006 · Cited by 183
Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review
Bortolato, B., Carvalho, A., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203823 · Cited by 181
“Moreover, drug-induced changes in appetite and energy balance may exert a detrimental effect on cognitive performance, as interferences in glucose metabolism translate into insulin resistance [135], neurotransmitters abnormal turnover, mitochondrial dysfunction and alterations in neuroplasticity [136].”
BackgroundYang, G., Zhu, K., Guo, W., Wu, D., Quan, X., Huang, X., Liu, S., Li, Y., Fang, H., Qiu, Y., et al. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202200457 · Cited by 177
Empathy and contextual social cognition
Melloni, M., López, V., & Ibáñez, A. M. (2013) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-013-0205-3 · Cited by 175
De Berardis, D., Fornaro, M., Valchera, A., Cavuto, M., Perna, G., Di Nicola, M., Serafini, G., Carano, A., Pompili, M., Vellante, F., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102888 · Cited by 174
5‐HT 6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia
Meffre, J., Chaumont‐Dubel, S., Mannoury la Cour, C., Loiseau, F., Watson, D. J. G., Dekeyne, A., Séveno, M., Rivet, J., Gaven, F., Déléris, P., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201410 · Cited by 172
Self-citationHagi, K., Nosaka, T., Dickinson, D., Lindenmayer, J. P., Lee, J., Friedman, J., Boyer, L., Han, M., Abdul-Rashid, N. A., & Correll, C. U. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0015 · Cited by 171
What should we do about student use of cognitive enhancers? An analysis of current evidence
RAGAN, C. I., Bárd, I., & Singh, I. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.016 · Cited by 170
Effects of serotonin 2A/1A receptor stimulation on social exclusion processing
Preller, K. H., Pokorny, T., Hock, A., Kraehenmann, R., Stämpfli, P., Seifritz, E., Scheidegger, M., & Vollenweider, F. X. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524187113 · Cited by 169
Augmentation of working memory training by transcranial direct current stimulation (tDCS)
Ruf, S. P., Fallgatter, A. J., & Plewnia, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-01055-1 · Cited by 167
Senkowski, D., & Gallinat, J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.034 · Cited by 166
The GABA Transaminase, ABAT, Is Essential for Mitochondrial Nucleoside Metabolism
Besse, A., Wu, P., Bruni, F., Donti, T., Graham, B. H., Craigen, W. J., McFarland, R., Moretti, P., Lalani, S., Scott, K. L., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.008 · Cited by 163
Course of Cognitive Development From Infancy to Early Adulthood in the Psychosis Spectrum
Mollon, J., David, A. S., Zammit, S., Lewis, G., & Reichenberg, A. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4327 · Cited by 161
CACNA1C: Association With Psychiatric Disorders, Behavior, and Neurogenesis
Moon, A. L., Haan, N., Wilkinson, L. S., Thomas, K. L., & Hall, J. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby096 · Cited by 161
Stiedl, O., Pappa, E., Konradsson-Geuken, Ã., & Ögren, S. O. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00162 · Cited by 157
Danese, A. (2020) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13160 · Cited by 157
Kandola, A., Hendrikse, J., Lucassen, P. J., & Yücel, M. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00373 · Cited by 155
“Secondly, psychiatric symptoms can be dichotomously described as being either affective or cognitive in nature, yet a disproportionate amount of the current literature has exclusively focussed on ameliorating affective symptoms (Millan et al., 2012).”
Millan, M. J. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.004 · Cited by 153
Self-citationTransgenerational Epigenetic Effects on Brain Functions
Bohacek, J., Gapp, K., Saab, B. J., & Mansuy, I. M. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.08.019 · Cited by 152
Self-citationCurrent Status of Cognitive Remediation for Psychiatric Disorders: A Review
Kim, E. J., Bahk, Y.-C., 오현주, Lee, W.-H., Lee, J.-S., & Choi, K. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00461 · Cited by 151
Veling, W., Lestestuiver, B., Jongma, M., Hoenders, H. J. R., & van Driel, C. (2021) · Journal of Medical Internet Research · doi:10.2196/17233 · Cited by 149
Neill, J. C., Harte, M., Haddad, P. M., Lydall, E. S., & Dwyer, D. M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.09.011 · Cited by 147
Leão, A. H. F. F., Sarmento‐Silva, A. J., dos Santos, J. R., Ribeiro, A. M., & Silva, R. H. (2015) · Brain Pathology · doi:10.1111/bpa.12253 · Cited by 146
McIntyre, R. S., Xiao, H. X., Syeda, K., Vinberg, M., Carvalho, A. F., Mansur, R. B., Maruschak, N., & Cha, D. S. (2015) · CNS Drugs · doi:10.1007/s40263-015-0263-x · Cited by 145
Neuroinflammation and cognition across psychiatric conditions
Fourrier, C., Singhal, G., & Baune, B. T. (2019) · CNS Spectrums · doi:10.1017/s1092852918001499 · Cited by 145
From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms
Kabir, Z. D., Martínez-Rivera, A., & Rajadhyaksha, A. M. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0532-0 · Cited by 145
Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders
Morozova, A. Y., Zorkina, Y., Abramova, O. V., Pavlova, O., Ka, P., Soloveva, K., Volkova, M., Alekseeva, P. A., Andryshchenko, A., Kostyuk, G. P., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031217 · Cited by 143
Factors related to preventive COVID-19 infection behaviors among people with mental illness
Chang, K., Strong, C., Pakpour, A. H., Griffiths, M. D., & Lin, C. (2020) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2020.07.032 · Cited by 139
Floriou-Servou, A., von Ziegler, L., Stalder, L., Sturman, O., Privitera, M., Rassi, A., Cremonesi, A., Thöny, B., & Bohacek, J. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.02.003 · Cited by 139
TAAR1 Modulates Cortical Glutamate NMDA Receptor Function
Espinoza, S., Lignani, G., Caffino, L., Maggi, S., Sukhanov, I., Leo, D., Mus, L., Emanuele, M., Ronzitti, G., Harmeier, A., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.65 · Cited by 137
Gapp, K., von Ziegler, L., Tweedie‐Cullen, R. Y., & Mansuy, I. M. (2014) · BioEssays · doi:10.1002/bies.201300116 · Cited by 136
Self-citationReduced default mode network suppression during a working memory task in remitted major depression
Bartova, L., Meyer, B. M., Diers, K., Rabl, U., Scharinger, C., Popovic, A., Pail, G., Kalcher, K., Boubela, R. N., Huemer, J., et al. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.02.025 · Cited by 135
“…information processing leading to adverse emotional nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). responsiveness, attention, and dysfunctional executive function (Nolen-Hoeksema, 1991; Beck, 2008; Disner et al., 2011; Elliott et al., 2011; Millan et al., 2012).”
BackgroundInfluentialPresynaptic serotonin 2A receptors modulate thalamocortical plasticity and associative learning
Barre, A., Berthoux, C., De Bundel, D., Valjent, E., Bockaert, J., Marin, P., & Bécamel, C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525586113 · Cited by 135
“, 5-HT6 receptors) (56) and account for their low efficiency against the currently untreated and strongly debilitating cognitive symptoms of schizophrenia.”
BackgroundKingsberg, S. A., Clayton, A. H., & Pfaus, J. G. (2015) · CNS Drugs · doi:10.1007/s40263-015-0288-1 · Cited by 134
Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growth
Duhr, F., Déléris, P., Raynaud, F., Sevéno, M., Morisset‐Lopez, S., la Cour, C. M., Millan, M. J., Bockaert, J., Marin, P., & Chaumont‐Dubel, S. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1547 · Cited by 133
Self-citationMillan, M. J., Goodwin, G. M., Meyer-Lindenberg, A., & Ove Ögren, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.016 · Cited by 132
Self-citationScarr, E., Millan, M. J., Bahn, S., Bertolino, A., Turck, C. W., Kapur, S., Möller, H.-J., & Dean, B. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv042 · Cited by 132
Self-citationChin, J., & Scharfman, H. E. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.11.040 · Cited by 132
The association between executive functioning and psychopathology: general or specific?
Bloemen, A. J. P., Oldehinkel, A. J., Laceulle, O. M., Ormel, J., Rommelse, N. N. J., & Hartman, C. A. (2018) · Psychological Medicine · doi:10.1017/s0033291717003269 · Cited by 131
Anderzhanova, E., Kirmeier, T., & Wotjak, C. T. (2017) · Neurobiology of Stress · doi:10.1016/j.ynstr.2017.03.003 · Cited by 131
Hwang, J. W., Egorova, N., Yang, X. Q., Zhang, W. Y., Chen, J., Yang, X. Y., Hu, L. J., Sun, S., Tu, Y., & Kong, J. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.174 · Cited by 130
Reynolds, L. M., Pokinko, M., Torres-Berrío, A., Cuesta, S., Lambert, L. C., Del Cid Pellitero, E., Wodzinski, M., Manitt, C., Krimpenfort, P., Kolb, B., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.06.009 · Cited by 129
“Furthermore, impaired cognitive control is a symptom that spans multiple diagnoses based on the Diagnostic and Statistical Manual of Mental Disorders (DSM), including those with an adolescent onset, suggesting that disrupted PFC development is a common link between psychiatric diseases (54; 74).”
BackgroundLearning and memory impairments in a neuroendocrine mouse model of anxiety/depression
Darcet, F., Mendez-David, I., Tritschler, L., Gardier, A. M., Guilloux, J.-P., & David, D. J. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00136 · Cited by 129
Shared vulnerability for connectome alterations across psychiatric and neurological brain disorders
de Lange, S. C., Scholtens, L. H., Initiative, A. D. N., van den Berg, L. H., Boks, M. P., Bozzali, M., Cahn, W., Dannlowski, U., Durston, S., Geuze, E., et al. (2019) · Nature Human Behaviour · doi:10.1038/s41562-019-0659-6 · Cited by 129
Neurophysiological symptoms and aspartame: What is the connection?
Choudhary, A. K., & Lee, Y. Y. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1288340 · Cited by 127
Breukelaar, I. A., Antees, C., Grieve, S. M., Foster, S. L., Gomes, L., Williams, L. M., & Korgaonkar, M. S. (2017) · Human Brain Mapping · doi:10.1002/hbm.23401 · Cited by 125
Millan, M. J., & Bales, K. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.09.012 · Cited by 125
Self-citationDunphy-Doherty, F., O'Mahony, S. M., Peterson, V. L., O'Sullivan, O., Crispie, F., Cotter, P. D., Wigmore, P., King, M. V., Cryan, J. F., & Fone, K. C. F. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.10.024 · Cited by 124
Zhang, Y., Shao, F., Wang, Q., Xie, X., & Wang, W. (2017) · Neural Plasticity · doi:10.1155/2017/9382797 · Cited by 124
Personalized machine learning of depressed mood using wearables
Shah, R. V., Grennan, G., Zafar-Khan, M., Alim, F., Dey, S., Ramanathan, D., & Mishra, J. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01445-0 · Cited by 123
Protein misfolding and amyloid nucleation through liquid–liquid phase separation
Mukherjee, S., Poudyal, M., Dave, K., Kadu, P., & Maji, S. K. (2024) · Chemical Society Reviews · doi:10.1039/d3cs01065a · Cited by 123
Metadata
- Authors
- Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., Dubois, B., Geyer, M. A., Goodwin, G. M., Gorwood, P., Jay, T. M., Joëls, M., Mansuy, I. M., Meyer-Lindenberg, A., Murphy, D., Rolls, E., Saletu, B., Spedding, M., Sweeney, J., Whittington, M., & Young, L. J.
- Affiliations
- Institut de Recherches Internationales Servier (France) (FR)
- Pitié-Salpêtrière Hospital (FR)
- University Hospitals of the Ruhr-University of Bochum (DE)
- University of Cambridge (GB)
- University of California, Davis (US)
- University of Massachusetts Dartmouth (US)
- Université Paris-Sud (FR)
- University of Pennsylvania (US)
- Institut du Cerveau (FR)
- University of California San Diego (US)
- Warneford Hospital (GB)
- Inserm (FR)
- University Medical Center Utrecht (NL)
- University of Zurich (CH)
- King's College London (GB)
- University of Warwick (GB)
- Medical University of Vienna (AT)
- Servier (France) (FR)
- The University of Texas Southwestern Medical Center (US)
- Newcastle University (GB)
- Emory University (US)
- Corresponding author
- Millan, Mark J.
- ORCID
- Millan, Mark J.
- Brüne, Martin
- Bullmore, Edward T.
- Carter, Cameron S.
- Clayton, Nicola S.
- Connor, Richard
- Davis, Sabrina
- DeRubeis, Robert J.
- Dubois, Bruno
- Geyer, Mark A.
- Goodwin, Guy M.
- Gorwood, Philip
- Jay, Thérèse M.
- Joëls, Marian
- Mansuy, Isabelle M.
- Murphy, Declan
- Rolls, Edmund
- Spedding, Michael
- Sweeney, John
- Whittington, Miles
- Young, Larry J.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-02
- Volume
- 11
- Issue
- 2
- Pages
- 141-168
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2080092700
- Cited by
- 1,292
- References
- 274
- Citations by year
- 2026: 80 · 2025: 110 · 2024: 107 · 2023: 104 · 2022: 105 · 2021: 97 · 2020: 96 · 2019: 97 · 2018: 86 · 2017: 74 · 2016: 87 · 2015: 75 · 2014: 63 · 2013: 78 · 2012: 30
- FWCI
- 10.62
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- National Institute for Health and Care Research (RP-PG-0606-1045, NF-SI-0509-10229)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- cognitive impairment, mental illness, depression, anxiety, hallucinations, translational research, animal models, cognitive function, quality of life, social and professional integration, cognitive therapy
- MeSH terms
- Mental Disorders, Brain, Cognition, Cognition Disorders, Humans, Magnetic Resonance Imaging, Neuropsychological Tests, Psychomotor Performance, Risk Factors, Stress, Psychological, Nootropic Agents, Genetic Predisposition to Disease, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.